nodes	percent_of_prediction	percent_of_DWPC	metapath
Memantine—HTR3A—enteric nervous system—Crohn's disease	0.107	0.497	CbGeAlD
Memantine—HTR3A—myenteric nerve plexus—Crohn's disease	0.0811	0.377	CbGeAlD
Memantine—SLC22A2—digestive system—Crohn's disease	0.00712	0.0331	CbGeAlD
Memantine—HTR3A—digestive system—Crohn's disease	0.00614	0.0285	CbGeAlD
Memantine—CYP2C19—digestive system—Crohn's disease	0.00388	0.018	CbGeAlD
Memantine—CYP2B6—skin of body—Crohn's disease	0.0038	0.0177	CbGeAlD
Memantine—CYP2B6—lymphoid tissue—Crohn's disease	0.00307	0.0143	CbGeAlD
Memantine—CYP2B6—digestive system—Crohn's disease	0.00304	0.0141	CbGeAlD
Memantine—Pancreatitis—Mesalazine—Crohn's disease	0.00198	0.00252	CcSEcCtD
Memantine—Infestation NOS—Azathioprine—Crohn's disease	0.00197	0.00252	CcSEcCtD
Memantine—Infestation—Azathioprine—Crohn's disease	0.00197	0.00252	CcSEcCtD
Memantine—Angina pectoris—Mesalazine—Crohn's disease	0.00196	0.00251	CcSEcCtD
Memantine—Stevens-Johnson syndrome—Azathioprine—Crohn's disease	0.00196	0.0025	CcSEcCtD
Memantine—Bronchitis—Mesalazine—Crohn's disease	0.00194	0.00247	CcSEcCtD
Memantine—Musculoskeletal discomfort—Mercaptopurine—Crohn's disease	0.00193	0.00246	CcSEcCtD
Memantine—Pancytopenia—Mesalazine—Crohn's disease	0.00192	0.00244	CcSEcCtD
Memantine—Neutropenia—Mesalazine—Crohn's disease	0.00189	0.0024	CcSEcCtD
Memantine—Dysuria—Mesalazine—Crohn's disease	0.00189	0.0024	CcSEcCtD
Memantine—Upper respiratory tract infection—Mesalazine—Crohn's disease	0.00187	0.00239	CcSEcCtD
Memantine—Arthropathy—Prednisone—Crohn's disease	0.00187	0.00239	CcSEcCtD
Memantine—Hepatobiliary disease—Azathioprine—Crohn's disease	0.00187	0.00238	CcSEcCtD
Memantine—Pollakiuria—Mesalazine—Crohn's disease	0.00186	0.00238	CcSEcCtD
Memantine—Agranulocytosis—Azathioprine—Crohn's disease	0.00184	0.00235	CcSEcCtD
Memantine—Decreased appetite—Mercaptopurine—Crohn's disease	0.00184	0.00234	CcSEcCtD
Memantine—Weight increased—Mesalazine—Crohn's disease	0.00184	0.00234	CcSEcCtD
Memantine—Weight decreased—Mesalazine—Crohn's disease	0.00182	0.00233	CcSEcCtD
Memantine—Gastrointestinal disorder—Mercaptopurine—Crohn's disease	0.00182	0.00233	CcSEcCtD
Memantine—Leukocytosis—Prednisone—Crohn's disease	0.00181	0.00231	CcSEcCtD
Memantine—Pneumonia—Mesalazine—Crohn's disease	0.00181	0.00231	CcSEcCtD
Memantine—Infestation NOS—Mesalazine—Crohn's disease	0.0018	0.00229	CcSEcCtD
Memantine—Infestation—Mesalazine—Crohn's disease	0.0018	0.00229	CcSEcCtD
Memantine—Hypercholesterolaemia—Prednisone—Crohn's disease	0.0018	0.00229	CcSEcCtD
Memantine—Depression—Mesalazine—Crohn's disease	0.00179	0.00229	CcSEcCtD
Memantine—Cataract—Prednisone—Crohn's disease	0.00179	0.00228	CcSEcCtD
Memantine—Stevens-Johnson syndrome—Mesalazine—Crohn's disease	0.00178	0.00227	CcSEcCtD
Memantine—Haemoglobin—Azathioprine—Crohn's disease	0.00178	0.00227	CcSEcCtD
Memantine—Haemorrhage—Azathioprine—Crohn's disease	0.00177	0.00226	CcSEcCtD
Memantine—Renal failure—Mesalazine—Crohn's disease	0.00177	0.00225	CcSEcCtD
Memantine—Neuropathy peripheral—Mesalazine—Crohn's disease	0.00176	0.00225	CcSEcCtD
Memantine—Conjunctivitis—Mesalazine—Crohn's disease	0.00175	0.00223	CcSEcCtD
Memantine—Urinary tract infection—Mesalazine—Crohn's disease	0.00175	0.00223	CcSEcCtD
Memantine—Haematuria—Mesalazine—Crohn's disease	0.00171	0.00219	CcSEcCtD
Memantine—Hepatobiliary disease—Mesalazine—Crohn's disease	0.0017	0.00217	CcSEcCtD
Memantine—Epistaxis—Mesalazine—Crohn's disease	0.0017	0.00216	CcSEcCtD
Memantine—Sinusitis—Mesalazine—Crohn's disease	0.00169	0.00215	CcSEcCtD
Memantine—Agranulocytosis—Mesalazine—Crohn's disease	0.00168	0.00214	CcSEcCtD
Memantine—Erythema multiforme—Azathioprine—Crohn's disease	0.00168	0.00214	CcSEcCtD
Memantine—Body temperature increased—Mercaptopurine—Crohn's disease	0.00167	0.00213	CcSEcCtD
Memantine—Skin exfoliation—Prednisone—Crohn's disease	0.00162	0.00207	CcSEcCtD
Memantine—Haemoglobin—Mesalazine—Crohn's disease	0.00162	0.00207	CcSEcCtD
Memantine—Rhinitis—Mesalazine—Crohn's disease	0.00162	0.00206	CcSEcCtD
Memantine—Hepatitis—Mesalazine—Crohn's disease	0.00161	0.00206	CcSEcCtD
Memantine—Haemorrhage—Mesalazine—Crohn's disease	0.00161	0.00206	CcSEcCtD
Memantine—Pharyngitis—Mesalazine—Crohn's disease	0.0016	0.00204	CcSEcCtD
Memantine—Immune system disorder—Azathioprine—Crohn's disease	0.0016	0.00204	CcSEcCtD
Memantine—Mediastinal disorder—Azathioprine—Crohn's disease	0.0016	0.00204	CcSEcCtD
Memantine—Neuropathy—Prednisone—Crohn's disease	0.0016	0.00204	CcSEcCtD
Memantine—Urinary tract disorder—Mesalazine—Crohn's disease	0.00159	0.00203	CcSEcCtD
Memantine—Oedema peripheral—Mesalazine—Crohn's disease	0.00159	0.00203	CcSEcCtD
Memantine—Chills—Azathioprine—Crohn's disease	0.00159	0.00203	CcSEcCtD
Memantine—Connective tissue disorder—Mesalazine—Crohn's disease	0.00159	0.00202	CcSEcCtD
Memantine—Arrhythmia—Azathioprine—Crohn's disease	0.00158	0.00202	CcSEcCtD
Memantine—Urethral disorder—Mesalazine—Crohn's disease	0.00158	0.00202	CcSEcCtD
Memantine—Alopecia—Azathioprine—Crohn's disease	0.00157	0.002	CcSEcCtD
Memantine—Hypersensitivity—Mercaptopurine—Crohn's disease	0.00156	0.00199	CcSEcCtD
Memantine—Oesophagitis—Prednisone—Crohn's disease	0.00155	0.00198	CcSEcCtD
Memantine—Erythema multiforme—Mesalazine—Crohn's disease	0.00153	0.00195	CcSEcCtD
Memantine—Pulmonary oedema—Prednisone—Crohn's disease	0.00151	0.00193	CcSEcCtD
Memantine—Eye disorder—Mesalazine—Crohn's disease	0.00151	0.00192	CcSEcCtD
Memantine—Tinnitus—Mesalazine—Crohn's disease	0.00151	0.00192	CcSEcCtD
Memantine—Cardiac disorder—Mesalazine—Crohn's disease	0.0015	0.00191	CcSEcCtD
Memantine—Hyperkinesia—Prednisone—Crohn's disease	0.00148	0.00189	CcSEcCtD
Memantine—Sepsis—Prednisone—Crohn's disease	0.00148	0.00188	CcSEcCtD
Memantine—Angiopathy—Mesalazine—Crohn's disease	0.00146	0.00187	CcSEcCtD
Memantine—Immune system disorder—Mesalazine—Crohn's disease	0.00146	0.00186	CcSEcCtD
Memantine—Mediastinal disorder—Mesalazine—Crohn's disease	0.00145	0.00186	CcSEcCtD
Memantine—Chills—Mesalazine—Crohn's disease	0.00145	0.00185	CcSEcCtD
Memantine—Diarrhoea—Mercaptopurine—Crohn's disease	0.00145	0.00184	CcSEcCtD
Memantine—Ill-defined disorder—Azathioprine—Crohn's disease	0.00143	0.00183	CcSEcCtD
Memantine—Alopecia—Mesalazine—Crohn's disease	0.00143	0.00182	CcSEcCtD
Memantine—Thrombophlebitis—Prednisone—Crohn's disease	0.00143	0.00182	CcSEcCtD
Memantine—Anaemia—Azathioprine—Crohn's disease	0.00143	0.00182	CcSEcCtD
Memantine—Diabetes mellitus—Prednisone—Crohn's disease	0.00142	0.00181	CcSEcCtD
Memantine—Mental disorder—Mesalazine—Crohn's disease	0.00141	0.0018	CcSEcCtD
Memantine—Malaise—Azathioprine—Crohn's disease	0.00139	0.00177	CcSEcCtD
Memantine—Flatulence—Mesalazine—Crohn's disease	0.00138	0.00177	CcSEcCtD
Memantine—Leukopenia—Azathioprine—Crohn's disease	0.00138	0.00176	CcSEcCtD
Memantine—Vascular purpura—Prednisone—Crohn's disease	0.00138	0.00176	CcSEcCtD
Memantine—Tension—Mesalazine—Crohn's disease	0.00138	0.00176	CcSEcCtD
Memantine—Dysgeusia—Mesalazine—Crohn's disease	0.00138	0.00175	CcSEcCtD
Memantine—Nervousness—Mesalazine—Crohn's disease	0.00136	0.00174	CcSEcCtD
Memantine—Cardiac failure congestive—Prednisone—Crohn's disease	0.00136	0.00174	CcSEcCtD
Memantine—Back pain—Mesalazine—Crohn's disease	0.00136	0.00173	CcSEcCtD
Memantine—Vomiting—Mercaptopurine—Crohn's disease	0.00134	0.00171	CcSEcCtD
Memantine—Injury—Prednisone—Crohn's disease	0.00134	0.00171	CcSEcCtD
Memantine—Rash—Mercaptopurine—Crohn's disease	0.00133	0.0017	CcSEcCtD
Memantine—Dermatitis—Mercaptopurine—Crohn's disease	0.00133	0.0017	CcSEcCtD
Memantine—Vision blurred—Mesalazine—Crohn's disease	0.00132	0.00169	CcSEcCtD
Memantine—Tremor—Mesalazine—Crohn's disease	0.00132	0.00168	CcSEcCtD
Memantine—Amnesia—Prednisone—Crohn's disease	0.00131	0.00168	CcSEcCtD
Memantine—Increased appetite—Prednisone—Crohn's disease	0.00131	0.00168	CcSEcCtD
Memantine—Arthralgia—Azathioprine—Crohn's disease	0.00131	0.00167	CcSEcCtD
Memantine—Myalgia—Azathioprine—Crohn's disease	0.00131	0.00167	CcSEcCtD
Memantine—Ill-defined disorder—Mesalazine—Crohn's disease	0.0013	0.00166	CcSEcCtD
Memantine—Anaemia—Mesalazine—Crohn's disease	0.0013	0.00166	CcSEcCtD
Memantine—Discomfort—Azathioprine—Crohn's disease	0.0013	0.00165	CcSEcCtD
Memantine—Purpura—Prednisone—Crohn's disease	0.00128	0.00163	CcSEcCtD
Memantine—Malaise—Mesalazine—Crohn's disease	0.00127	0.00162	CcSEcCtD
Memantine—Cardiac failure—Prednisone—Crohn's disease	0.00126	0.00161	CcSEcCtD
Memantine—Vertigo—Mesalazine—Crohn's disease	0.00126	0.00161	CcSEcCtD
Memantine—Syncope—Mesalazine—Crohn's disease	0.00126	0.00161	CcSEcCtD
Memantine—Lethargy—Prednisone—Crohn's disease	0.00126	0.00161	CcSEcCtD
Memantine—Leukopenia—Mesalazine—Crohn's disease	0.00126	0.0016	CcSEcCtD
Memantine—Nausea—Mercaptopurine—Crohn's disease	0.00126	0.0016	CcSEcCtD
Memantine—Infection—Azathioprine—Crohn's disease	0.00125	0.0016	CcSEcCtD
Memantine—Palpitations—Mesalazine—Crohn's disease	0.00124	0.00158	CcSEcCtD
Memantine—Loss of consciousness—Mesalazine—Crohn's disease	0.00124	0.00158	CcSEcCtD
Memantine—Gastrointestinal haemorrhage—Prednisone—Crohn's disease	0.00123	0.00157	CcSEcCtD
Memantine—Osteoarthritis—Prednisone—Crohn's disease	0.00123	0.00157	CcSEcCtD
Memantine—Thrombocytopenia—Azathioprine—Crohn's disease	0.00123	0.00157	CcSEcCtD
Memantine—Cough—Mesalazine—Crohn's disease	0.00123	0.00156	CcSEcCtD
Memantine—Skin disorder—Azathioprine—Crohn's disease	0.00122	0.00156	CcSEcCtD
Memantine—Affect lability—Prednisone—Crohn's disease	0.00122	0.00155	CcSEcCtD
Memantine—Hypertension—Mesalazine—Crohn's disease	0.00121	0.00155	CcSEcCtD
Memantine—Psychotic disorder—Prednisone—Crohn's disease	0.00121	0.00154	CcSEcCtD
Memantine—Chest pain—Mesalazine—Crohn's disease	0.0012	0.00153	CcSEcCtD
Memantine—Arthralgia—Mesalazine—Crohn's disease	0.0012	0.00153	CcSEcCtD
Memantine—Myalgia—Mesalazine—Crohn's disease	0.0012	0.00153	CcSEcCtD
Memantine—Anxiety—Mesalazine—Crohn's disease	0.00119	0.00152	CcSEcCtD
Memantine—Discomfort—Mesalazine—Crohn's disease	0.00118	0.00151	CcSEcCtD
Memantine—Irritability—Prednisone—Crohn's disease	0.00118	0.0015	CcSEcCtD
Memantine—Hypotension—Azathioprine—Crohn's disease	0.00118	0.0015	CcSEcCtD
Memantine—Cardiac arrest—Prednisone—Crohn's disease	0.00117	0.0015	CcSEcCtD
Memantine—Dry mouth—Mesalazine—Crohn's disease	0.00117	0.00149	CcSEcCtD
Memantine—Mood swings—Prednisone—Crohn's disease	0.00117	0.00149	CcSEcCtD
Memantine—Confusional state—Mesalazine—Crohn's disease	0.00116	0.00147	CcSEcCtD
Memantine—Musculoskeletal discomfort—Azathioprine—Crohn's disease	0.00115	0.00146	CcSEcCtD
Memantine—Oedema—Mesalazine—Crohn's disease	0.00115	0.00146	CcSEcCtD
Memantine—Infection—Mesalazine—Crohn's disease	0.00114	0.00145	CcSEcCtD
Memantine—Dry skin—Prednisone—Crohn's disease	0.00113	0.00144	CcSEcCtD
Memantine—Shock—Mesalazine—Crohn's disease	0.00113	0.00144	CcSEcCtD
Memantine—Nervous system disorder—Mesalazine—Crohn's disease	0.00112	0.00143	CcSEcCtD
Memantine—Hypokalaemia—Prednisone—Crohn's disease	0.00112	0.00143	CcSEcCtD
Memantine—Thrombocytopenia—Mesalazine—Crohn's disease	0.00112	0.00143	CcSEcCtD
Memantine—Tachycardia—Mesalazine—Crohn's disease	0.00112	0.00143	CcSEcCtD
Memantine—Skin disorder—Mesalazine—Crohn's disease	0.00111	0.00142	CcSEcCtD
Memantine—Hyperhidrosis—Mesalazine—Crohn's disease	0.00111	0.00141	CcSEcCtD
Memantine—Anorexia—Mesalazine—Crohn's disease	0.00109	0.00139	CcSEcCtD
Memantine—Muscular weakness—Prednisone—Crohn's disease	0.00109	0.00139	CcSEcCtD
Memantine—Alanine aminotransferase increased—Prednisone—Crohn's disease	0.00109	0.00139	CcSEcCtD
Memantine—Gastrointestinal disorder—Azathioprine—Crohn's disease	0.00109	0.00139	CcSEcCtD
Memantine—Hypotension—Mesalazine—Crohn's disease	0.00107	0.00137	CcSEcCtD
Memantine—Pancreatitis—Prednisone—Crohn's disease	0.00105	0.00133	CcSEcCtD
Memantine—Musculoskeletal discomfort—Mesalazine—Crohn's disease	0.00104	0.00133	CcSEcCtD
Memantine—Sweating increased—Prednisone—Crohn's disease	0.00104	0.00133	CcSEcCtD
Memantine—Feeling abnormal—Azathioprine—Crohn's disease	0.00104	0.00132	CcSEcCtD
Memantine—Insomnia—Mesalazine—Crohn's disease	0.00104	0.00132	CcSEcCtD
Memantine—Paraesthesia—Mesalazine—Crohn's disease	0.00103	0.00131	CcSEcCtD
Memantine—Gastrointestinal pain—Azathioprine—Crohn's disease	0.00103	0.00131	CcSEcCtD
Memantine—Dyspnoea—Mesalazine—Crohn's disease	0.00102	0.0013	CcSEcCtD
Memantine—Somnolence—Mesalazine—Crohn's disease	0.00102	0.0013	CcSEcCtD
Memantine—Dyspepsia—Mesalazine—Crohn's disease	0.00101	0.00129	CcSEcCtD
Memantine—Neutropenia—Prednisone—Crohn's disease	0.000998	0.00127	CcSEcCtD
Memantine—Decreased appetite—Mesalazine—Crohn's disease	0.000997	0.00127	CcSEcCtD
Memantine—Abdominal pain—Azathioprine—Crohn's disease	0.000995	0.00127	CcSEcCtD
Memantine—Body temperature increased—Azathioprine—Crohn's disease	0.000995	0.00127	CcSEcCtD
Memantine—Gastrointestinal disorder—Mesalazine—Crohn's disease	0.00099	0.00126	CcSEcCtD
Memantine—Fatigue—Mesalazine—Crohn's disease	0.000989	0.00126	CcSEcCtD
Memantine—Erectile dysfunction—Prednisone—Crohn's disease	0.000983	0.00125	CcSEcCtD
Memantine—Constipation—Mesalazine—Crohn's disease	0.000981	0.00125	CcSEcCtD
Memantine—Pain—Mesalazine—Crohn's disease	0.000981	0.00125	CcSEcCtD
Memantine—Weight increased—Prednisone—Crohn's disease	0.000971	0.00124	CcSEcCtD
Memantine—Weight decreased—Prednisone—Crohn's disease	0.000965	0.00123	CcSEcCtD
Memantine—Hyperglycaemia—Prednisone—Crohn's disease	0.000962	0.00123	CcSEcCtD
Memantine—Depression—Prednisone—Crohn's disease	0.000949	0.00121	CcSEcCtD
Memantine—Feeling abnormal—Mesalazine—Crohn's disease	0.000945	0.00121	CcSEcCtD
Memantine—Acute coronary syndrome—Prednisone—Crohn's disease	0.000938	0.0012	CcSEcCtD
Memantine—Gastrointestinal pain—Mesalazine—Crohn's disease	0.000938	0.0012	CcSEcCtD
Memantine—Myocardial infarction—Prednisone—Crohn's disease	0.000933	0.00119	CcSEcCtD
Memantine—Neuropathy peripheral—Prednisone—Crohn's disease	0.000933	0.00119	CcSEcCtD
Memantine—Hypersensitivity—Azathioprine—Crohn's disease	0.000928	0.00118	CcSEcCtD
Memantine—Urticaria—Mesalazine—Crohn's disease	0.000911	0.00116	CcSEcCtD
Memantine—Abdominal pain—Mesalazine—Crohn's disease	0.000907	0.00116	CcSEcCtD
Memantine—Body temperature increased—Mesalazine—Crohn's disease	0.000907	0.00116	CcSEcCtD
Memantine—Bradycardia—Prednisone—Crohn's disease	0.000869	0.00111	CcSEcCtD
Memantine—Diarrhoea—Azathioprine—Crohn's disease	0.000861	0.0011	CcSEcCtD
Memantine—Haemoglobin—Prednisone—Crohn's disease	0.000858	0.00109	CcSEcCtD
Memantine—Haemorrhage—Prednisone—Crohn's disease	0.000854	0.00109	CcSEcCtD
Memantine—Hallucination—Prednisone—Crohn's disease	0.00085	0.00108	CcSEcCtD
Memantine—Hypersensitivity—Mesalazine—Crohn's disease	0.000845	0.00108	CcSEcCtD
Memantine—Connective tissue disorder—Prednisone—Crohn's disease	0.000839	0.00107	CcSEcCtD
Memantine—Dizziness—Azathioprine—Crohn's disease	0.000833	0.00106	CcSEcCtD
Memantine—Asthenia—Mesalazine—Crohn's disease	0.000823	0.00105	CcSEcCtD
Memantine—Pruritus—Mesalazine—Crohn's disease	0.000811	0.00103	CcSEcCtD
Memantine—Vomiting—Azathioprine—Crohn's disease	0.0008	0.00102	CcSEcCtD
Memantine—Eye disorder—Prednisone—Crohn's disease	0.000798	0.00102	CcSEcCtD
Memantine—Rash—Azathioprine—Crohn's disease	0.000794	0.00101	CcSEcCtD
Memantine—Dermatitis—Azathioprine—Crohn's disease	0.000793	0.00101	CcSEcCtD
Memantine—Flushing—Prednisone—Crohn's disease	0.000793	0.00101	CcSEcCtD
Memantine—Headache—Azathioprine—Crohn's disease	0.000789	0.00101	CcSEcCtD
Memantine—Diarrhoea—Mesalazine—Crohn's disease	0.000785	0.001	CcSEcCtD
Memantine—Angiopathy—Prednisone—Crohn's disease	0.000775	0.000988	CcSEcCtD
Memantine—Immune system disorder—Prednisone—Crohn's disease	0.000771	0.000984	CcSEcCtD
Memantine—Arrhythmia—Prednisone—Crohn's disease	0.000763	0.000973	CcSEcCtD
Memantine—Dizziness—Mesalazine—Crohn's disease	0.000758	0.000967	CcSEcCtD
Memantine—Alopecia—Prednisone—Crohn's disease	0.000755	0.000962	CcSEcCtD
Memantine—Mental disorder—Prednisone—Crohn's disease	0.000748	0.000954	CcSEcCtD
Memantine—Nausea—Azathioprine—Crohn's disease	0.000748	0.000954	CcSEcCtD
Memantine—Malnutrition—Prednisone—Crohn's disease	0.000743	0.000948	CcSEcCtD
Memantine—Vomiting—Mesalazine—Crohn's disease	0.000729	0.00093	CcSEcCtD
Memantine—Rash—Mesalazine—Crohn's disease	0.000723	0.000922	CcSEcCtD
Memantine—Dermatitis—Mesalazine—Crohn's disease	0.000722	0.000921	CcSEcCtD
Memantine—Headache—Mesalazine—Crohn's disease	0.000718	0.000916	CcSEcCtD
Memantine—Vision blurred—Prednisone—Crohn's disease	0.000701	0.000894	CcSEcCtD
Memantine—Ill-defined disorder—Prednisone—Crohn's disease	0.00069	0.00088	CcSEcCtD
Memantine—Anaemia—Prednisone—Crohn's disease	0.000687	0.000876	CcSEcCtD
Memantine—Agitation—Prednisone—Crohn's disease	0.000683	0.000871	CcSEcCtD
Memantine—Nausea—Mesalazine—Crohn's disease	0.000681	0.000869	CcSEcCtD
Memantine—Malaise—Prednisone—Crohn's disease	0.00067	0.000855	CcSEcCtD
Memantine—Vertigo—Prednisone—Crohn's disease	0.000668	0.000852	CcSEcCtD
Memantine—Syncope—Prednisone—Crohn's disease	0.000667	0.00085	CcSEcCtD
Memantine—Loss of consciousness—Prednisone—Crohn's disease	0.000653	0.000833	CcSEcCtD
Memantine—Convulsion—Prednisone—Crohn's disease	0.000644	0.000821	CcSEcCtD
Memantine—Hypertension—Prednisone—Crohn's disease	0.000642	0.000819	CcSEcCtD
Memantine—Myalgia—Prednisone—Crohn's disease	0.000633	0.000807	CcSEcCtD
Memantine—Arthralgia—Prednisone—Crohn's disease	0.000633	0.000807	CcSEcCtD
Memantine—Anxiety—Prednisone—Crohn's disease	0.000631	0.000804	CcSEcCtD
Memantine—Discomfort—Prednisone—Crohn's disease	0.000625	0.000798	CcSEcCtD
Memantine—Oedema—Prednisone—Crohn's disease	0.000607	0.000774	CcSEcCtD
Memantine—Infection—Prednisone—Crohn's disease	0.000603	0.000769	CcSEcCtD
Memantine—Shock—Prednisone—Crohn's disease	0.000597	0.000761	CcSEcCtD
Memantine—Nervous system disorder—Prednisone—Crohn's disease	0.000595	0.000759	CcSEcCtD
Memantine—Tachycardia—Prednisone—Crohn's disease	0.000592	0.000755	CcSEcCtD
Memantine—Skin disorder—Prednisone—Crohn's disease	0.000589	0.000752	CcSEcCtD
Memantine—Hyperhidrosis—Prednisone—Crohn's disease	0.000587	0.000748	CcSEcCtD
Memantine—Anorexia—Prednisone—Crohn's disease	0.000578	0.000738	CcSEcCtD
Memantine—Musculoskeletal discomfort—Prednisone—Crohn's disease	0.000553	0.000705	CcSEcCtD
Memantine—Insomnia—Prednisone—Crohn's disease	0.000549	0.0007	CcSEcCtD
Memantine—Paraesthesia—Prednisone—Crohn's disease	0.000545	0.000695	CcSEcCtD
Memantine—Dyspepsia—Prednisone—Crohn's disease	0.000534	0.000681	CcSEcCtD
Memantine—Decreased appetite—Prednisone—Crohn's disease	0.000527	0.000673	CcSEcCtD
Memantine—Fatigue—Prednisone—Crohn's disease	0.000523	0.000667	CcSEcCtD
Memantine—Constipation—Prednisone—Crohn's disease	0.000519	0.000662	CcSEcCtD
Memantine—Feeling abnormal—Prednisone—Crohn's disease	0.0005	0.000638	CcSEcCtD
Memantine—Gastrointestinal pain—Prednisone—Crohn's disease	0.000496	0.000633	CcSEcCtD
Memantine—Urticaria—Prednisone—Crohn's disease	0.000482	0.000615	CcSEcCtD
Memantine—Body temperature increased—Prednisone—Crohn's disease	0.00048	0.000612	CcSEcCtD
Memantine—Abdominal pain—Prednisone—Crohn's disease	0.00048	0.000612	CcSEcCtD
Memantine—Hypersensitivity—Prednisone—Crohn's disease	0.000447	0.00057	CcSEcCtD
Memantine—Asthenia—Prednisone—Crohn's disease	0.000435	0.000555	CcSEcCtD
Memantine—Pruritus—Prednisone—Crohn's disease	0.000429	0.000547	CcSEcCtD
Memantine—Diarrhoea—Prednisone—Crohn's disease	0.000415	0.000529	CcSEcCtD
Memantine—Dizziness—Prednisone—Crohn's disease	0.000401	0.000512	CcSEcCtD
Memantine—Vomiting—Prednisone—Crohn's disease	0.000386	0.000492	CcSEcCtD
Memantine—Rash—Prednisone—Crohn's disease	0.000383	0.000488	CcSEcCtD
Memantine—Dermatitis—Prednisone—Crohn's disease	0.000382	0.000487	CcSEcCtD
Memantine—Headache—Prednisone—Crohn's disease	0.00038	0.000485	CcSEcCtD
Memantine—Nausea—Prednisone—Crohn's disease	0.00036	0.00046	CcSEcCtD
Memantine—SLC22A2—Organic cation transport—SLC22A4—Crohn's disease	9.65e-05	0.114	CbGpPWpGaD
Memantine—SLC22A2—Organic cation transport—SLC22A5—Crohn's disease	9.65e-05	0.114	CbGpPWpGaD
Memantine—SLC22A2—Organic cation/anion/zwitterion transport—SLC22A5—Crohn's disease	6.54e-05	0.0772	CbGpPWpGaD
Memantine—SLC22A2—Organic cation/anion/zwitterion transport—SLC22A4—Crohn's disease	6.54e-05	0.0772	CbGpPWpGaD
Memantine—GRIN1—BDNF signaling pathway—KSR1—Crohn's disease	2.85e-05	0.0337	CbGpPWpGaD
Memantine—GRIN2B—BDNF signaling pathway—KSR1—Crohn's disease	2.78e-05	0.0328	CbGpPWpGaD
Memantine—HTR3A—SIDS Susceptibility Pathways—CREM—Crohn's disease	2.44e-05	0.0288	CbGpPWpGaD
Memantine—GRIN1—SIDS Susceptibility Pathways—CREM—Crohn's disease	2.03e-05	0.0239	CbGpPWpGaD
Memantine—SLC22A2—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC22A5—Crohn's disease	1.31e-05	0.0155	CbGpPWpGaD
Memantine—SLC22A2—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC22A4—Crohn's disease	1.31e-05	0.0155	CbGpPWpGaD
Memantine—GRIN2B—ErbB4 signaling events—JAK2—Crohn's disease	1.16e-05	0.0137	CbGpPWpGaD
Memantine—CYP2A6—Quercetin and Nf-kB/ AP-1 Induced Cell Apoptosis—PTGS2—Crohn's disease	9.98e-06	0.0118	CbGpPWpGaD
Memantine—CYP2C19—Arachidonic acid metabolism—GPX4—Crohn's disease	9.09e-06	0.0107	CbGpPWpGaD
Memantine—SLC22A2—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC11A1—Crohn's disease	8.16e-06	0.00964	CbGpPWpGaD
Memantine—DRD2—Circadian rythm related genes—CREM—Crohn's disease	7.6e-06	0.00897	CbGpPWpGaD
Memantine—HTR3A—SIDS Susceptibility Pathways—IL10—Crohn's disease	7.21e-06	0.00851	CbGpPWpGaD
Memantine—DRD2—GPCRs, Class A Rhodopsin-like—ACKR2—Crohn's disease	7.17e-06	0.00847	CbGpPWpGaD
Memantine—HTR3A—Transmembrane transport of small molecules—SLC22A4—Crohn's disease	7e-06	0.00826	CbGpPWpGaD
Memantine—HTR3A—Transmembrane transport of small molecules—SLC22A5—Crohn's disease	7e-06	0.00826	CbGpPWpGaD
Memantine—GRIN2A—Alzheimers Disease—IL1B—Crohn's disease	6.22e-06	0.00734	CbGpPWpGaD
Memantine—DRD2—Class A/1 (Rhodopsin-like receptors)—ACKR2—Crohn's disease	6.15e-06	0.00726	CbGpPWpGaD
Memantine—GRIN1—Spinal Cord Injury—TLR4—Crohn's disease	6.05e-06	0.00714	CbGpPWpGaD
Memantine—GRIN1—SIDS Susceptibility Pathways—IL10—Crohn's disease	6e-06	0.00708	CbGpPWpGaD
Memantine—SLC22A2—SLC-mediated transmembrane transport—SLC22A5—Crohn's disease	5.96e-06	0.00703	CbGpPWpGaD
Memantine—SLC22A2—SLC-mediated transmembrane transport—SLC22A4—Crohn's disease	5.96e-06	0.00703	CbGpPWpGaD
Memantine—DRD2—Class A/1 (Rhodopsin-like receptors)—MLN—Crohn's disease	5.83e-06	0.00688	CbGpPWpGaD
Memantine—GRIN1—Spinal Cord Injury—ICAM1—Crohn's disease	5.8e-06	0.00684	CbGpPWpGaD
Memantine—GRIN1—Alzheimers Disease—IL1B—Crohn's disease	5.42e-06	0.0064	CbGpPWpGaD
Memantine—GRIN2B—Alzheimers Disease—IL1B—Crohn's disease	5.29e-06	0.00624	CbGpPWpGaD
Memantine—DRD2—G alpha (i) signalling events—CCR9—Crohn's disease	5.08e-06	0.006	CbGpPWpGaD
Memantine—HTR3A—Transmembrane transport of small molecules—GCKR—Crohn's disease	4.93e-06	0.00582	CbGpPWpGaD
Memantine—DRD2—GPCRs, Class A Rhodopsin-like—CCR9—Crohn's disease	4.71e-06	0.00556	CbGpPWpGaD
Memantine—DRD2—GPCR ligand binding—ACKR2—Crohn's disease	4.68e-06	0.00552	CbGpPWpGaD
Memantine—GRIN2A—Alzheimers Disease—TNF—Crohn's disease	4.51e-06	0.00533	CbGpPWpGaD
Memantine—DRD2—GPCR ligand binding—MLN—Crohn's disease	4.44e-06	0.00524	CbGpPWpGaD
Memantine—CYP2B6—Metapathway biotransformation—GPX4—Crohn's disease	4.42e-06	0.00521	CbGpPWpGaD
Memantine—GRIN1—Spinal Cord Injury—IFNG—Crohn's disease	4.41e-06	0.00521	CbGpPWpGaD
Memantine—DRD2—GPCRs, Class A Rhodopsin-like—GPR65—Crohn's disease	4.38e-06	0.00517	CbGpPWpGaD
Memantine—HTR3A—Transmembrane transport of small molecules—SLC11A1—Crohn's disease	4.36e-06	0.00514	CbGpPWpGaD
Memantine—GRIN1—Spinal Cord Injury—PTGS2—Crohn's disease	4.23e-06	0.00499	CbGpPWpGaD
Memantine—SLC22A2—SLC-mediated transmembrane transport—GCKR—Crohn's disease	4.2e-06	0.00495	CbGpPWpGaD
Memantine—GRIN1—Spinal Cord Injury—CXCL8—Crohn's disease	4.1e-06	0.00484	CbGpPWpGaD
Memantine—DRD2—Class A/1 (Rhodopsin-like receptors)—CCR9—Crohn's disease	4.04e-06	0.00477	CbGpPWpGaD
Memantine—HTR3A—SIDS Susceptibility Pathways—CXCL8—Crohn's disease	3.94e-06	0.00465	CbGpPWpGaD
Memantine—GRIN1—Alzheimers Disease—TNF—Crohn's disease	3.94e-06	0.00464	CbGpPWpGaD
Memantine—GRIN1—Spinal Cord Injury—IL1B—Crohn's disease	3.93e-06	0.00464	CbGpPWpGaD
Memantine—GRIN2B—Alzheimers Disease—TNF—Crohn's disease	3.84e-06	0.00453	CbGpPWpGaD
Memantine—GRIN1—BDNF signaling pathway—JAK2—Crohn's disease	3.83e-06	0.00452	CbGpPWpGaD
Memantine—HTR3A—SIDS Susceptibility Pathways—IL1B—Crohn's disease	3.78e-06	0.00446	CbGpPWpGaD
Memantine—DRD2—Class A/1 (Rhodopsin-like receptors)—GPR65—Crohn's disease	3.76e-06	0.00443	CbGpPWpGaD
Memantine—GRIN2B—BDNF signaling pathway—JAK2—Crohn's disease	3.74e-06	0.00441	CbGpPWpGaD
Memantine—SLC22A2—SLC-mediated transmembrane transport—SLC11A1—Crohn's disease	3.71e-06	0.00438	CbGpPWpGaD
Memantine—DRD2—G alpha (i) signalling events—CCR6—Crohn's disease	3.37e-06	0.00397	CbGpPWpGaD
Memantine—CYP2C19—Metapathway biotransformation—GPX4—Crohn's disease	3.34e-06	0.00394	CbGpPWpGaD
Memantine—GRIN1—SIDS Susceptibility Pathways—CXCL8—Crohn's disease	3.28e-06	0.00387	CbGpPWpGaD
Memantine—GRIN1—SIDS Susceptibility Pathways—IL1B—Crohn's disease	3.15e-06	0.00371	CbGpPWpGaD
Memantine—DRD2—GPCRs, Class A Rhodopsin-like—CCR6—Crohn's disease	3.12e-06	0.00369	CbGpPWpGaD
Memantine—DRD2—GPCR ligand binding—CCR9—Crohn's disease	3.08e-06	0.00363	CbGpPWpGaD
Memantine—SLC22A2—Transmembrane transport of small molecules—SLC22A5—Crohn's disease	3.03e-06	0.00357	CbGpPWpGaD
Memantine—SLC22A2—Transmembrane transport of small molecules—SLC22A4—Crohn's disease	3.03e-06	0.00357	CbGpPWpGaD
Memantine—DRD2—GPCR ligand binding—GPR65—Crohn's disease	2.86e-06	0.00337	CbGpPWpGaD
Memantine—GRIN1—Spinal Cord Injury—TNF—Crohn's disease	2.85e-06	0.00337	CbGpPWpGaD
Memantine—GRIN1—BDNF signaling pathway—STAT3—Crohn's disease	2.81e-06	0.00332	CbGpPWpGaD
Memantine—DRD2—GPCRs, Class A Rhodopsin-like—PTGER4—Crohn's disease	2.75e-06	0.00325	CbGpPWpGaD
Memantine—HTR3A—SIDS Susceptibility Pathways—TNF—Crohn's disease	2.74e-06	0.00324	CbGpPWpGaD
Memantine—GRIN2B—BDNF signaling pathway—STAT3—Crohn's disease	2.74e-06	0.00324	CbGpPWpGaD
Memantine—DRD2—Class A/1 (Rhodopsin-like receptors)—CCR6—Crohn's disease	2.68e-06	0.00316	CbGpPWpGaD
Memantine—DRD2—GPCR downstream signaling—MLN—Crohn's disease	2.51e-06	0.00296	CbGpPWpGaD
Memantine—CYP2C19—Arachidonic acid metabolism—PTGS2—Crohn's disease	2.45e-06	0.00289	CbGpPWpGaD
Memantine—DRD2—Signaling by GPCR—ACKR2—Crohn's disease	2.4e-06	0.00284	CbGpPWpGaD
Memantine—DRD2—Class A/1 (Rhodopsin-like receptors)—PTGER4—Crohn's disease	2.36e-06	0.00278	CbGpPWpGaD
Memantine—GRIN1—Spinal Cord Injury—IL6—Crohn's disease	2.3e-06	0.00272	CbGpPWpGaD
Memantine—GRIN1—Developmental Biology—SMAD3—Crohn's disease	2.3e-06	0.00271	CbGpPWpGaD
Memantine—GRIN1—SIDS Susceptibility Pathways—TNF—Crohn's disease	2.28e-06	0.00269	CbGpPWpGaD
Memantine—DRD2—Signaling by GPCR—MLN—Crohn's disease	2.28e-06	0.00269	CbGpPWpGaD
Memantine—GRIN2B—Developmental Biology—SMAD3—Crohn's disease	2.24e-06	0.00264	CbGpPWpGaD
Memantine—HTR3A—SIDS Susceptibility Pathways—IL6—Crohn's disease	2.21e-06	0.00261	CbGpPWpGaD
Memantine—SLC22A2—Transmembrane transport of small molecules—GCKR—Crohn's disease	2.13e-06	0.00252	CbGpPWpGaD
Memantine—GRIN1—Axon guidance—TYK2—Crohn's disease	2.1e-06	0.00248	CbGpPWpGaD
Memantine—CYP2C19—Metabolism of lipids and lipoproteins—PLA2G4F—Crohn's disease	2.1e-06	0.00247	CbGpPWpGaD
Memantine—GRIN2B—Axon guidance—TYK2—Crohn's disease	2.05e-06	0.00242	CbGpPWpGaD
Memantine—DRD2—GPCR ligand binding—CCR6—Crohn's disease	2.04e-06	0.0024	CbGpPWpGaD
Memantine—GRIN1—Axon guidance—JAK2—Crohn's disease	2e-06	0.00236	CbGpPWpGaD
Memantine—GRIN2B—Axon guidance—JAK2—Crohn's disease	1.95e-06	0.0023	CbGpPWpGaD
Memantine—SLC22A2—Transmembrane transport of small molecules—SLC11A1—Crohn's disease	1.89e-06	0.00222	CbGpPWpGaD
Memantine—GRIN1—SIDS Susceptibility Pathways—IL6—Crohn's disease	1.84e-06	0.00217	CbGpPWpGaD
Memantine—DRD2—GPCR ligand binding—PTGER4—Crohn's disease	1.79e-06	0.00212	CbGpPWpGaD
Memantine—CYP2C19—Metabolism of lipids and lipoproteins—MTMR3—Crohn's disease	1.78e-06	0.0021	CbGpPWpGaD
Memantine—DRD2—GPCR downstream signaling—CCR9—Crohn's disease	1.74e-06	0.00205	CbGpPWpGaD
Memantine—SLC22A2—Metabolism—PLA2G4F—Crohn's disease	1.67e-06	0.00197	CbGpPWpGaD
Memantine—DRD2—GPCR downstream signaling—GPR65—Crohn's disease	1.62e-06	0.00191	CbGpPWpGaD
Memantine—DRD2—Signaling by GPCR—CCR9—Crohn's disease	1.58e-06	0.00186	CbGpPWpGaD
Memantine—HTR3A—Transmembrane transport of small molecules—ALB—Crohn's disease	1.57e-06	0.00185	CbGpPWpGaD
Memantine—CYP2A6—Metabolism—PLA2G4F—Crohn's disease	1.53e-06	0.00181	CbGpPWpGaD
Memantine—GRIN1—Developmental Biology—TYK2—Crohn's disease	1.5e-06	0.00177	CbGpPWpGaD
Memantine—DRD2—Signaling by GPCR—GPR65—Crohn's disease	1.47e-06	0.00173	CbGpPWpGaD
Memantine—GRIN2B—Developmental Biology—TYK2—Crohn's disease	1.46e-06	0.00172	CbGpPWpGaD
Memantine—GRIN1—Developmental Biology—JAK2—Crohn's disease	1.43e-06	0.00169	CbGpPWpGaD
Memantine—DRD2—Signaling Pathways—ACKR2—Crohn's disease	1.42e-06	0.00167	CbGpPWpGaD
Memantine—SLC22A2—Metabolism—MTMR3—Crohn's disease	1.42e-06	0.00167	CbGpPWpGaD
Memantine—GRIN2B—Developmental Biology—JAK2—Crohn's disease	1.39e-06	0.00164	CbGpPWpGaD
Memantine—CYP2C19—Metabolism of lipids and lipoproteins—FADS1—Crohn's disease	1.39e-06	0.00164	CbGpPWpGaD
Memantine—DRD2—Signaling Pathways—MLN—Crohn's disease	1.35e-06	0.00159	CbGpPWpGaD
Memantine—SLC22A2—SLC-mediated transmembrane transport—ALB—Crohn's disease	1.34e-06	0.00158	CbGpPWpGaD
Memantine—CYP2A6—Metabolism—MTMR3—Crohn's disease	1.3e-06	0.00154	CbGpPWpGaD
Memantine—CYP2C19—Metabolism of lipids and lipoproteins—GPX4—Crohn's disease	1.3e-06	0.00153	CbGpPWpGaD
Memantine—CYP2B6—Metabolism—PLA2G4F—Crohn's disease	1.23e-06	0.00146	CbGpPWpGaD
Memantine—DRD2—Signaling Pathways—TAGAP—Crohn's disease	1.23e-06	0.00145	CbGpPWpGaD
Memantine—DRD2—GPCR downstream signaling—CCR6—Crohn's disease	1.15e-06	0.00136	CbGpPWpGaD
Memantine—SLC22A2—Metabolism—FADS1—Crohn's disease	1.1e-06	0.0013	CbGpPWpGaD
Memantine—DRD2—G alpha (i) signalling events—CXCL8—Crohn's disease	1.08e-06	0.00128	CbGpPWpGaD
Memantine—DRD2—Signaling Pathways—RSPO3—Crohn's disease	1.08e-06	0.00127	CbGpPWpGaD
Memantine—CYP2B6—Metabolism—MTMR3—Crohn's disease	1.05e-06	0.00124	CbGpPWpGaD
Memantine—GRIN1—Developmental Biology—STAT3—Crohn's disease	1.05e-06	0.00124	CbGpPWpGaD
Memantine—DRD2—Signaling by GPCR—CCR6—Crohn's disease	1.05e-06	0.00123	CbGpPWpGaD
Memantine—SLC22A2—Metabolism—GPX4—Crohn's disease	1.03e-06	0.00122	CbGpPWpGaD
Memantine—GRIN1—Axon guidance—IL6—Crohn's disease	1.03e-06	0.00121	CbGpPWpGaD
Memantine—GRIN2B—Developmental Biology—STAT3—Crohn's disease	1.02e-06	0.00121	CbGpPWpGaD
Memantine—DRD2—Signaling Pathways—SEL1L—Crohn's disease	1.02e-06	0.0012	CbGpPWpGaD
Memantine—CYP2A6—Metabolism—FADS1—Crohn's disease	1.01e-06	0.0012	CbGpPWpGaD
Memantine—DRD2—GPCR downstream signaling—PTGER4—Crohn's disease	1.01e-06	0.0012	CbGpPWpGaD
Memantine—GRIN2B—Axon guidance—IL6—Crohn's disease	1e-06	0.00118	CbGpPWpGaD
Memantine—SLC22A2—Metabolism—GCKR—Crohn's disease	9.99e-07	0.00118	CbGpPWpGaD
Memantine—CYP2A6—Metabolism—GPX4—Crohn's disease	9.49e-07	0.00112	CbGpPWpGaD
Memantine—CYP2C19—Metabolism—PLA2G4F—Crohn's disease	9.33e-07	0.0011	CbGpPWpGaD
Memantine—DRD2—Signaling Pathways—CCR9—Crohn's disease	9.32e-07	0.0011	CbGpPWpGaD
Memantine—DRD2—Signaling by GPCR—PTGER4—Crohn's disease	9.21e-07	0.00109	CbGpPWpGaD
Memantine—CYP2A6—Metabolism—GCKR—Crohn's disease	9.17e-07	0.00108	CbGpPWpGaD
Memantine—GRIN1—Developmental Biology—TNF—Crohn's disease	9.08e-07	0.00107	CbGpPWpGaD
Memantine—GRIN2B—Developmental Biology—TNF—Crohn's disease	8.85e-07	0.00104	CbGpPWpGaD
Memantine—DRD2—Signaling Pathways—GPR65—Crohn's disease	8.67e-07	0.00102	CbGpPWpGaD
Memantine—DRD2—GPCR downstream signaling—IL3—Crohn's disease	8.63e-07	0.00102	CbGpPWpGaD
Memantine—DRD2—Class A/1 (Rhodopsin-like receptors)—CXCL8—Crohn's disease	8.62e-07	0.00102	CbGpPWpGaD
Memantine—DRD2—GPCR downstream signaling—RASGRP1—Crohn's disease	8.35e-07	0.000986	CbGpPWpGaD
Memantine—CYP2B6—Metabolism—FADS1—Crohn's disease	8.18e-07	0.000966	CbGpPWpGaD
Memantine—CYP2C19—Metabolism—MTMR3—Crohn's disease	7.93e-07	0.000937	CbGpPWpGaD
Memantine—DRD2—Signaling by GPCR—IL3—Crohn's disease	7.84e-07	0.000925	CbGpPWpGaD
Memantine—CYP2B6—Metabolism—GPX4—Crohn's disease	7.66e-07	0.000904	CbGpPWpGaD
Memantine—DRD2—Signaling by GPCR—RASGRP1—Crohn's disease	7.58e-07	0.000895	CbGpPWpGaD
Memantine—CYP2B6—Metabolism—GCKR—Crohn's disease	7.4e-07	0.000873	CbGpPWpGaD
Memantine—GRIN1—Developmental Biology—IL6—Crohn's disease	7.33e-07	0.000865	CbGpPWpGaD
Memantine—GRIN2B—Developmental Biology—IL6—Crohn's disease	7.14e-07	0.000843	CbGpPWpGaD
Memantine—DRD2—Circadian rythm related genes—IL6—Crohn's disease	6.9e-07	0.000815	CbGpPWpGaD
Memantine—SLC22A2—Transmembrane transport of small molecules—ALB—Crohn's disease	6.79e-07	0.000801	CbGpPWpGaD
Memantine—DRD2—GPCR ligand binding—CXCL8—Crohn's disease	6.57e-07	0.000775	CbGpPWpGaD
Memantine—CYP2C19—Metabolism—FADS1—Crohn's disease	6.18e-07	0.00073	CbGpPWpGaD
Memantine—DRD2—Signaling Pathways—CCR6—Crohn's disease	6.18e-07	0.000729	CbGpPWpGaD
Memantine—DRD2—GPCR downstream signaling—IL2RA—Crohn's disease	6.05e-07	0.000714	CbGpPWpGaD
Memantine—CYP2C19—Metabolism—GPX4—Crohn's disease	5.79e-07	0.000683	CbGpPWpGaD
Memantine—CYP2C19—Metabolism—GCKR—Crohn's disease	5.59e-07	0.00066	CbGpPWpGaD
Memantine—DRD2—Signaling Pathways—RBX1—Crohn's disease	5.59e-07	0.000659	CbGpPWpGaD
Memantine—DRD2—Signaling by GPCR—IL2RA—Crohn's disease	5.49e-07	0.000648	CbGpPWpGaD
Memantine—DRD2—Signaling Pathways—PTGER4—Crohn's disease	5.44e-07	0.000642	CbGpPWpGaD
Memantine—DRD2—Signaling Pathways—UBE2D1—Crohn's disease	4.9e-07	0.000578	CbGpPWpGaD
Memantine—DRD2—Signaling Pathways—RIPK2—Crohn's disease	4.75e-07	0.000561	CbGpPWpGaD
Memantine—DRD2—Signaling Pathways—IL3—Crohn's disease	4.63e-07	0.000547	CbGpPWpGaD
Memantine—DRD2—Signaling Pathways—RASGRP1—Crohn's disease	4.48e-07	0.000529	CbGpPWpGaD
Memantine—DRD2—GPCR downstream signaling—JAK2—Crohn's disease	4.07e-07	0.00048	CbGpPWpGaD
Memantine—DRD2—Signaling Pathways—SOCS1—Crohn's disease	4.06e-07	0.000479	CbGpPWpGaD
Memantine—CYP2C19—Metabolism of lipids and lipoproteins—ALB—Crohn's disease	4e-07	0.000472	CbGpPWpGaD
Memantine—DRD2—Signaling by GPCR—TYK2—Crohn's disease	3.87e-07	0.000457	CbGpPWpGaD
Memantine—DRD2—GPCR downstream signaling—CXCL8—Crohn's disease	3.71e-07	0.000438	CbGpPWpGaD
Memantine—DRD2—Signaling by GPCR—JAK2—Crohn's disease	3.69e-07	0.000436	CbGpPWpGaD
Memantine—DRD2—Signaling Pathways—SMAD3—Crohn's disease	3.5e-07	0.000414	CbGpPWpGaD
Memantine—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—Crohn's disease	3.5e-07	0.000413	CbGpPWpGaD
Memantine—DRD2—Signaling by GPCR—CXCL8—Crohn's disease	3.37e-07	0.000398	CbGpPWpGaD
Memantine—DRD2—Signaling Pathways—IL2RA—Crohn's disease	3.24e-07	0.000383	CbGpPWpGaD
Memantine—SLC22A2—Metabolism—ALB—Crohn's disease	3.18e-07	0.000375	CbGpPWpGaD
Memantine—CYP2A6—Metabolism—ALB—Crohn's disease	2.92e-07	0.000344	CbGpPWpGaD
Memantine—SLC22A2—Metabolism—PTGS2—Crohn's disease	2.78e-07	0.000328	CbGpPWpGaD
Memantine—CYP2A6—Metabolism—PTGS2—Crohn's disease	2.55e-07	0.000301	CbGpPWpGaD
Memantine—CYP2B6—Metabolism—ALB—Crohn's disease	2.35e-07	0.000278	CbGpPWpGaD
Memantine—DRD2—Signaling Pathways—TYK2—Crohn's disease	2.29e-07	0.00027	CbGpPWpGaD
Memantine—DRD2—Signaling Pathways—JAK2—Crohn's disease	2.18e-07	0.000257	CbGpPWpGaD
Memantine—CYP2B6—Metabolism—PTGS2—Crohn's disease	2.06e-07	0.000243	CbGpPWpGaD
Memantine—DRD2—Signaling Pathways—CXCL8—Crohn's disease	1.99e-07	0.000235	CbGpPWpGaD
Memantine—DRD2—Signaling by GPCR—IL6—Crohn's disease	1.89e-07	0.000223	CbGpPWpGaD
Memantine—CYP2C19—Metabolism—ALB—Crohn's disease	1.78e-07	0.00021	CbGpPWpGaD
Memantine—DRD2—Signaling Pathways—STAT3—Crohn's disease	1.6e-07	0.000189	CbGpPWpGaD
Memantine—CYP2C19—Metabolism—PTGS2—Crohn's disease	1.56e-07	0.000184	CbGpPWpGaD
Memantine—DRD2—Signaling Pathways—IL6—Crohn's disease	1.12e-07	0.000132	CbGpPWpGaD
